vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and Clearwater Analytics Holdings, Inc. (CWAN). Click either name above to swap in a different company.

Clearwater Analytics Holdings, Inc. is the larger business by last-quarter revenue ($217.5M vs $121.8M, roughly 1.8× Core Laboratories Inc.). Core Laboratories Inc. runs the higher net margin — 4.2% vs -5.4%, a 9.6% gap on every dollar of revenue. On growth, Clearwater Analytics Holdings, Inc. posted the faster year-over-year revenue change (72.0% vs -1.4%). Clearwater Analytics Holdings, Inc. produced more free cash flow last quarter ($52.3M vs $517.0K). Over the past eight quarters, Clearwater Analytics Holdings, Inc.'s revenue compounded faster (45.5% CAGR vs -3.4%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Clearwater Analytics Holdings, Inc. is an American software-as-a-service (SaaS) fintech company that provides automated investment accounting, performance, compliance, and risk reporting worldwide. Clearwater is a publicly traded company headquartered in Boise, Idaho, with additional offices in London, Edinburgh, New York City and Noida.

CLB vs CWAN — Head-to-Head

Bigger by revenue
CWAN
CWAN
1.8× larger
CWAN
$217.5M
$121.8M
CLB
Growing faster (revenue YoY)
CWAN
CWAN
+73.4% gap
CWAN
72.0%
-1.4%
CLB
Higher net margin
CLB
CLB
9.6% more per $
CLB
4.2%
-5.4%
CWAN
More free cash flow
CWAN
CWAN
$51.8M more FCF
CWAN
$52.3M
$517.0K
CLB
Faster 2-yr revenue CAGR
CWAN
CWAN
Annualised
CWAN
45.5%
-3.4%
CLB

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLB
CLB
CWAN
CWAN
Revenue
$121.8M
$217.5M
Net Profit
$5.1M
$-11.8M
Gross Margin
67.2%
Operating Margin
1.5%
-3.1%
Net Margin
4.2%
-5.4%
Revenue YoY
-1.4%
72.0%
Net Profit YoY
-102.8%
EPS (diluted)
$0.11
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
CWAN
CWAN
Q1 26
$121.8M
Q4 25
$138.3M
$217.5M
Q3 25
$134.5M
$205.1M
Q2 25
$130.2M
$181.9M
Q1 25
$123.6M
$126.9M
Q4 24
$129.2M
$126.5M
Q3 24
$134.4M
$115.8M
Q2 24
$130.6M
$106.8M
Net Profit
CLB
CLB
CWAN
CWAN
Q1 26
$5.1M
Q4 25
$4.9M
$-11.8M
Q3 25
$14.2M
$-10.3M
Q2 25
$10.6M
$-23.2M
Q1 25
$-154.0K
$6.5M
Q4 24
$7.4M
$419.3M
Q3 24
$11.7M
$3.6M
Q2 24
$9.0M
$-430.0K
Gross Margin
CLB
CLB
CWAN
CWAN
Q1 26
Q4 25
20.8%
67.2%
Q3 25
22.0%
65.6%
Q2 25
20.3%
65.1%
Q1 25
19.5%
73.3%
Q4 24
17.8%
73.5%
Q3 24
20.5%
72.9%
Q2 24
21.2%
72.0%
Operating Margin
CLB
CLB
CWAN
CWAN
Q1 26
1.5%
Q4 25
11.5%
-3.1%
Q3 25
15.6%
3.2%
Q2 25
11.7%
-8.0%
Q1 25
3.6%
5.6%
Q4 24
11.0%
1.0%
Q3 24
14.7%
6.3%
Q2 24
12.3%
3.6%
Net Margin
CLB
CLB
CWAN
CWAN
Q1 26
4.2%
Q4 25
3.6%
-5.4%
Q3 25
10.6%
-5.0%
Q2 25
8.2%
-12.8%
Q1 25
-0.1%
5.1%
Q4 24
5.7%
331.5%
Q3 24
8.7%
3.1%
Q2 24
6.9%
-0.4%
EPS (diluted)
CLB
CLB
CWAN
CWAN
Q1 26
$0.11
Q4 25
$0.11
$-0.04
Q3 25
$0.30
$-0.04
Q2 25
$0.22
$-0.09
Q1 25
$0.00
$0.03
Q4 24
$0.15
$1.65
Q3 24
$0.25
$0.02
Q2 24
$0.19
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
CWAN
CWAN
Cash + ST InvestmentsLiquidity on hand
$22.8M
$91.2M
Total DebtLower is stronger
$822.6M
Stockholders' EquityBook value
$275.1M
$2.0B
Total Assets
$587.7M
$3.0B
Debt / EquityLower = less leverage
0.41×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
CWAN
CWAN
Q1 26
$22.8M
Q4 25
$22.7M
$91.2M
Q3 25
$25.6M
$64.1M
Q2 25
$31.2M
$71.9M
Q1 25
$22.1M
$282.9M
Q4 24
$19.2M
$255.5M
Q3 24
$21.5M
$305.8M
Q2 24
$17.7M
$257.9M
Total Debt
CLB
CLB
CWAN
CWAN
Q1 26
Q4 25
$110.3M
$822.6M
Q3 25
$114.1M
$838.9M
Q2 25
$124.6M
$878.1M
Q1 25
$124.4M
Q4 24
$126.1M
$43.3M
Q3 24
$139.9M
Q2 24
$147.6M
Stockholders' Equity
CLB
CLB
CWAN
CWAN
Q1 26
$275.1M
Q4 25
$266.0M
$2.0B
Q3 25
$271.3M
$2.0B
Q2 25
$261.3M
$2.0B
Q1 25
$253.4M
$1.1B
Q4 24
$246.6M
$1.0B
Q3 24
$250.7M
$403.2M
Q2 24
$240.3M
$380.6M
Total Assets
CLB
CLB
CWAN
CWAN
Q1 26
$587.7M
Q4 25
$584.0M
$3.0B
Q3 25
$591.4M
$3.0B
Q2 25
$602.1M
$3.0B
Q1 25
$591.5M
$1.3B
Q4 24
$585.1M
$1.2B
Q3 24
$600.5M
$623.5M
Q2 24
$597.8M
$585.1M
Debt / Equity
CLB
CLB
CWAN
CWAN
Q1 26
Q4 25
0.41×
0.41×
Q3 25
0.42×
0.42×
Q2 25
0.48×
0.45×
Q1 25
0.49×
Q4 24
0.51×
0.04×
Q3 24
0.56×
Q2 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
CWAN
CWAN
Operating Cash FlowLast quarter
$4.0M
$55.3M
Free Cash FlowOCF − Capex
$517.0K
$52.3M
FCF MarginFCF / Revenue
0.4%
24.0%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
0.77×
TTM Free Cash FlowTrailing 4 quarters
$22.5M
$164.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
CWAN
CWAN
Q1 26
$4.0M
Q4 25
$7.9M
$55.3M
Q3 25
$8.5M
$49.0M
Q2 25
$13.9M
$47.1M
Q1 25
$6.7M
$24.5M
Q4 24
$20.6M
$-29.2M
Q3 24
$13.1M
$49.6M
Q2 24
$17.1M
$43.9M
Free Cash Flow
CLB
CLB
CWAN
CWAN
Q1 26
$517.0K
Q4 25
$5.0M
$52.3M
Q3 25
$6.5M
$44.9M
Q2 25
$10.4M
$44.1M
Q1 25
$3.9M
$23.0M
Q4 24
$17.4M
$-30.0M
Q3 24
$10.4M
$48.1M
Q2 24
$14.3M
$42.4M
FCF Margin
CLB
CLB
CWAN
CWAN
Q1 26
0.4%
Q4 25
3.6%
24.0%
Q3 25
4.8%
21.9%
Q2 25
8.0%
24.2%
Q1 25
3.1%
18.2%
Q4 24
13.4%
-23.7%
Q3 24
7.7%
41.5%
Q2 24
10.9%
39.7%
Capex Intensity
CLB
CLB
CWAN
CWAN
Q1 26
Q4 25
2.1%
1.4%
Q3 25
1.5%
2.0%
Q2 25
2.7%
1.6%
Q1 25
2.3%
1.2%
Q4 24
2.5%
0.6%
Q3 24
2.0%
1.3%
Q2 24
2.2%
1.4%
Cash Conversion
CLB
CLB
CWAN
CWAN
Q1 26
0.77×
Q4 25
1.61×
Q3 25
0.60×
Q2 25
1.31×
Q1 25
3.76×
Q4 24
2.78×
-0.07×
Q3 24
1.12×
13.66×
Q2 24
1.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons